We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SAN:EURONEXT PARISSanofi SA Analysis

Data as of 2026-07-05 - not real-time

$13.95

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Banco Santander is trading firmly above its short‑ and medium‑term moving averages, with a bullish MACD crossover that supports the current upward momentum. The RSI is in the high range, suggesting the stock is approaching overbought levels, while trading volume has been tapering, hinting at a possible short‑term pause near recent resistance. The bank’s valuation appears attractive relative to peers, with a price‑earnings multiple notably below the industry average and a dividend yield close to two percent backed by a modest payout ratio, indicating sustainable income. However, the 30‑day price volatility is elevated and the beta exceeds one, reflecting heightened sensitivity to market swings, and the recent drawdown history points to downside risk.
Overall, the fundamentals remain solid with steady earnings, a diversified business model, and a healthy dividend, but the limited upside from the current price level and the technical overbought signal temper enthusiasm for immediate upside bets.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price is near resistance and RSI signals overbought conditions
  • Decreasing volume may precede a short‑term pullback
  • Technical bullishness is offset by limited upside potential

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Valuation gap relative to industry peers
  • Sustainable dividend yield with low payout ratio
  • Diversified revenue streams and improving earnings outlook

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong franchise across retail, corporate, and wealth management
  • Continued dividend support and potential for earnings growth
  • Resilience of the banking model despite higher volatility

Key Metrics & Analysis

Financial Health

Revenue Growth4.60%
Profit Margin34.10%
P/E Ratio13.8
ROE12.89%
ROA0.78%
P/B Ratio1.7
Op. Cash Flow$-15418000384
Industry P/E17.5

Technical Analysis

TrendBullish
RSI69.3
Support$11.91
Resistance$14.18
MA 20$13.12
MA 50$12.52
MA 200$11.58
MACDBullish
VolumeDecreasing
Fear & Greed Index93.2

Valuation

Target Price$12.16
Upside/Downside-12.86%
GradeFair
TypeValue
Dividend Yield1.99%

Risk Assessment

Beta1.62
Volatility32.29%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.